Abstract：Objective: To investigate the expression significance of serum anti-basic fibroblast growth factor (bFGF) autoantibodies in patients with active autoimmune diseases. Methods: The clinical data of 139 patients with active autoimmune diseases were retrospectively analyzed. 46 healthy subjects who were admitted to the hospital for physical examination at the same time were used as control group. The levels of serum anti-bFGF-immunoglobulin (Ig)G antibody and anti-bFGF-IgM antibody were compared among patients with different types of diseases and kidney damage, and the correlation between the above indicators and urinary albumin excretion rate (UAER) and its predictive value on kidney damage were analyzed by Pearson correlation coefficient model and receiver operating characteristic (ROC) curve respectively. Results: The levels of serum anti-bFGF-IgG antibody and anti-bFGF-IgM antibody in patients with active systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), rheumatoid arthritis (RA) and other types of autoimmune diseases were significantly higher than those of healthy subjects, and the levels in RA patients were significantly higher than those in SLE patients (P<0.05). The levels of serum anti-bFGF-IgG antibody, anti-bFGF-IgM antibody and UAER in patients with autoimmune diseases and kidney damage were significantly higher than those of patients with non-kidney damage (P<0.05). Levels of serum anti-bFGF-IgG antibody and anti-bFGF-IgM antibody in patients with active autoimmune diseases showed a significant positive correlation with UAER level (r>0, P<0.05). There was nos ignificant difference in the area under ROC curve (AUC) of serum anti-bFGF-IgG antibody and anti-bFGF-IgM antibody in predicting kidney damage in patients with active autoimmune diseases (P>0.05), and the prediction sensitivities were 83.33% and 91.67%, ans the specificities were 64.08% and 61.17%, and the cut-off values were 208.01×10-3 and 224.79×10-3 respectively. Conclusion: The expressions of anti-bFGF autoantibodies are significantly increased in patients with active autoimmune diseases. Clinical testing can provide a reference for disease assessment and lay a foundation for pathological mechanism research.
毛洪博, 孟凡杰, 谭婷婷. 血清抗bFGF自身抗体在活动期自身免疫性疾病中的检测价值分析[J]. 河北医学, 2020, 26(2): 338-341.
MAO Hongbo, et al. Analysis of Detection Value of Serum Anti-bFGF Autoantibodies in Active Autoimmune Aiseases. HeBei Med, 2020, 26(2): 338-341.
[1] Rose NR. Prediction and prevention of autoimmune disease in the 21st century: a review and preview[J]. Am Epidemiol, 2016, 183(5):403~406. [2] Gutierrez-Arcelus M, Rich SS, Raychaudhuri S. Autoimmune diseases - connecting risk alleles with molecular traits of the immune system[J]. Nat Rev Genet, 2016, 17(3):160~174. [3] 温晓婷,李永哲.自身免疫病新自身抗体的筛选方法研究进展[J].中华风湿病学杂志,2016,20(1):59~62. [4] 曲婧格,王也,李熙萌,等.系统性红斑狼疮患者外周血单个核细胞中RSAD2表达及意义[J].山东医药,2018,58(30):62~64. [5] 李曼丽,杨朝阳,李晓光.壳聚糖载体加载碱性成纤维细胞因子诱导成年大鼠骨髓间充质干细胞分化为神经细胞的研究[J].中国现代医学杂志,2017,27(13):1~5. [6] Liwinski T, Schramm C. Autoimmune hepatitis-update on clinical management in 2017[J]. Clin Res Hepatol Gastroenterol, 2017, 41(6):617~625. [7] Wiersinga WM. Advances in treatment of active, moderate-to-severe graves' ophthalmopathy.[J]. Lancet Diabetes Endocrinol, 2017, 5(2):134~142. [8] 张峥嵘,吴虹,戴丽,等.1-磷酸鞘氨醇及受体对自身免疫性疾病血管新生的影响[J].中国药理学通报,2017,33(9):1190~1194. [9] 赵凤芝,赵建夫,孙一帆,等.碱性成纤维细胞生长因子单克隆抗体联合洛铂对肺腺癌A549细胞增殖和凋亡的影响[J].中国肿瘤生物治疗杂志,2016,23(6):783~788.
2020, Vol. 26 
冀公网安备13080202000677号